Pulsed mesotherapy of immunoassociated dermatoses

Immunomodulating pulsed mesotherapy (IPMT) is described. Suspension of a long acting glucocorticoid (betamethsone, 7 mg/month, or triamcinolol, 40 mg/month) is diluted in saline and injected intracutaneously into the foci once a month. This treatment is effective in immunoassociated chronic dermatoses - atopic dermatitis, eczema, psoriasis, chronic urticaria in adults, adolescents, and children. This treatment is a convenient alternative to topical corticosteroids; in nonsevere dermatoses dermatoses it is a sufficient pathogenetic therapy. The advantages of IPMT are a convenient protocol - injections just once a month; the effect manifests from the very first days and is stable, relapses are becoming more and more rare and less severe; the total glucocorticoid dose in IPMT is even less than in topical corticosteroid therapy; the treatment is safe due to permissible fixed dose of the drug and its reliable natural reduction. The quality of life improves, the patient no longer depends on the use of ointments, the procedures are rare and easily tolerated; temporary disability is shorter, no hospitalization is needed.

immunomodulating pulsed mesotherapy, glucocorticoid minidose, atopic dermatitis, eczema, psoriasis, chronic urticaria, quality of life